Critical role for inflammasome-independent IL-1β production in osteomyelitis

J. Lukens,J. M. Gross,C. Calabrese,Y. Iwakura,M. Lamkanfi,P. Vogel,T. Kanneganti

Published 2013 in Proceedings of the National Academy of Sciences of the United States of America

ABSTRACT

Significance The IL-1 cytokines, IL-1α and IL-1β, are proinflammatory cytokines that are implicated in numerous inflammatory and autoimmune diseases. This study demonstrates that dysregulated immune responses centrally contribute to the pathogenesis of osteomyelitis and identifies a critical role for IL-1β in driving the inflammatory cascade that provokes bone destruction. Caspase-1 activation in the inflammasome complex is the most well established mechanism for IL-1β secretion. Interestingly, inflammasome-independent sources of IL-1β were found to provoke inflammation and osteolytic bone disease. Our findings establish a unique role for inflammasome-independent IL-1β in autoinflammatory bone disease and osteomyelitis, and identify proline–serine–threonine phosphatase interacting protein 2 as a negative regulator of inflammasome-autonomous IL-1β. The immune system plays an important role in the pathophysiology of many acute and chronic bone disorders, but the specific inflammatory networks that regulate individual bone disorders remain to be elucidated. Here, we characterized the osteoimmunological underpinnings of osteolytic bone disease in Pstpip2cmo mice. These mice carry a homozygous L98P missense mutation in the Pombe Cdc15 homology family phosphatase PSTPIP2 that is responsible for the development of a persistent autoinflammatory disease resembling chronic recurrent multifocal osteomyelitis in humans. We found that improper regulation of IL-1β production resulted in secondary induction of inflammatory cytokines, inflammatory cell infiltration in the bone, and unremitting bone inflammation. Aberrant Il1β expression precedes the development of osteolytic damage in young Pstpip2cmo mice, and genetic deletion of Il1r and Il1β, but not Il1α, rescued osteolytic bone disease in mutant mice. Intriguingly, caspase-1 and nucleotide-binding oligomerization domain (NOD)-like receptor family, pyrin domain containing 3 activation in the inflammasome complex were dispensable for Pstpip2cmo-mediated bone disease. Thus, our findings establish a critical role for inflammasome-independent production of IL-1β in osteolytic bone disease and identify PSTPIP2 as a negative regulator of caspase-1–autonomous IL-1β production.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-36 of 36 references · Page 1 of 1

CITED BY

Showing 1-100 of 124 citing papers · Page 1 of 2